Invesco Ltd. Agios Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 118,020 shares of AGIO stock, worth $6.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

118,020

Previous 76,202 54.88%

Holding current value

$6.09 Million

Previous $2.23 Million 128.41%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$27.55 - $48.83 $1.15 Million - $2.04 Million	41,818 Added 54.88%	118,020 $5.09 Million
Q1 2024 May 14, 2024	SELL	$21.32 - $34.81 $82,870 - $135,306	-3,887 Reduced 4.85%	76,202 $2.23 Million
Q4 2023 Feb 12, 2024	SELL	$19.97 - $24.53 $2.48 Million - $3.05 Million	-124,357 Reduced 60.83%	80,089 $1.78 Million
Q3 2023 Nov 13, 2023	BUY	$24.36 - $28.18 $3.14 Million - $3.63 Million	128,748 Added 170.08%	204,446 $5.06 Million
Q2 2023 Aug 11, 2023	BUY	$21.38 - $29.19 $79,341 - $108,324	3,711 Added 5.16%	75,698 $2.14 Million
Q1 2023 May 12, 2023	SELL	$21.74 - $30.93 $339,578 - $483,126	-15,620 Reduced 17.83%	71,987 $1.65 Million
Q4 2022 Feb 13, 2023	BUY	$24.81 - $31.52 $330,692 - $420,130	13,329 Added 17.94%	87,607 $2.46 Million
Q3 2022 Nov 14, 2022	SELL	$19.51 - $34.14 $90,545 - $158,443	-4,641 Reduced 5.88%	74,278 $2.1 Million
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $38,930 - $71,700	2,282 Added 2.98%	78,919 $1.75 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $34.81 $1.16 Million - $1.51 Million	43,504 Added 131.3%	76,637 $2.23 Million
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $138,759 - $233,517	-4,691 Reduced 12.4%	33,133 $1.09 Million
Q3 2021 Nov 15, 2021	BUY	$41.92 - $58.18 $53,741 - $74,586	1,282 Added 3.51%	37,824 $1.75 Million
Q2 2021 Aug 17, 2021	SELL	$52.06 - $61.27 $242,026 - $284,844	-4,649 Reduced 11.29%	36,542 $2.01 Million
Q1 2021 May 17, 2021	BUY	$44.23 - $57.5 $61,347 - $79,752	1,387 Added 3.48%	41,191 $2.13 Million
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $453,648 - $635,736	13,660 Added 52.25%	39,804 $1.73 Million
Q3 2020 Nov 16, 2020	SELL	$33.87 - $55.93 $41.2 Million - $68.1 Million	-1,217,095 Reduced 97.9%	26,144 $915,000
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $833,276 - $1.29 Million	24,188 Added 1.98%	1,243,239 $66.5 Million
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $5.8 Million - $9.9 Million	-184,021 Reduced 13.12%	1,219,051 $43.3 Million
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $2.78 Million - $4.67 Million	92,293 Added 7.04%	1,403,072 $67 Million
Q3 2019 Nov 14, 2019	SELL	$32.4 - $49.58 $2.79 Million - $4.26 Million	-85,994 Reduced 6.16%	1,310,779 $42.5 Million
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $25.7 Million - $37.9 Million	556,825 Added 66.29%	1,396,773 $69.7 Million
Q1 2019 May 15, 2019	SELL	$45.92 - $67.67 $78,339 - $115,445	-1,706 Reduced 0.2%	839,948 $56.6 Million
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $36 Million - $64.4 Million	841,654 New	841,654 $38.8 Million

Others Institutions Holding AGIO

# of Institutions

226

Shares Held

56.2M

Call Options Held

275K

Put Options Held

251K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.83B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account